Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TMSNY Stock Summary
In the News
Temenos shares crash even further as Swiss firm vows to review short-seller's claims
Temenos shares fell further on Tuesday as the Swiss company continued to suffer from allegations raised against it by short-seller Hindenburg Research, despite vowing to launch an independent review of the claims which have caused its stock price to crash.
Temenos AG (TMSNY) Q4 2023 Earnings Call Transcript
Temenos AG (TMSNY) Q4 2023 Earnings Call Transcript
Temenos sees slower earnings growth in 2024
Temenos on Monday forecast slower growth in 2024 earnings before interest and taxes (EBIT) compared to last year when its results beat expectations on solid deal execution.
Temenos boss must go following Hindenburg scalping, says activist
Petrus Advisers, a London-based activist investor of Swiss software firm Temenos, has called for the company to sack its interim chief executive Andreas Andreades following a damning short-selling report from New York firm Hindenburg Research. In a detailed report published on Thursday, New York-based short seller Hindenburg laid down a litany of accusations against Geneva-listed Temenos, ranging from financial mishandling, poor product quality and insider selling.
Hindenburg's latest short target Temenos rejects allegations as share price tumbles
Temenos shares slid following allegations of accounting misconduct by short-seller Hindenburg Research, which the Swiss software company denies.
Temenos shares slide a second day as short seller's allegations wipe $2 billion off market cap
Temenos shares continued to crash on Friday, despite the Swiss technology firm's attempt to hit back at allegations made by short seller Hindenburg Research that have knocked more than $2 billion off its market capitalization.
Temenos shares extend slide after Hindenburg allegations
Shares in Temenos fell more than 9% on Friday, a day after a Hindenburg Research report alleging accounting irregularities wiped off more than a quarter of the Swiss software company's market value.
Temenos responds to Hindenburg's short report on Thursday
Temenos AG have recovered slightly in the past hour after it said it “fundamentally refutes” a short report that Hindenburg Research published today. Allegations that Hindenburg made in its short report Shares of the enterprise software company crash as much as 35% this morning after Hindenburg announced a short position in $TEMN.
Temenos AG (TMNSF) Q4 2022 Earnings Call Transcript
Temenos AG (OTCPK:TMNSF) Q4 2022 Earnings Conference Call February 20, 2023 12:30 PM ET Company Participants Andreas Andreades - Executive Chairman and Acting CEO Panagiotis Spiliopoulos - Chief Financial Officer Conference Call Participants James Goodman - Barclays Chandra Sriraman - Stifel Toby Ogg - JPMorgan Charlie Brennan - Jefferies Michael Briest - UBS Frederic Boulan - Bank of America Knut Woller - Baader Bank Mohammed Moawalla - Goldman Sachs Justin Forsythe - Credit Suisse Gianmarco Conti - Deutsche Bank Operator Ladies and gentlemen, welcome to the Temenos Q4 2022 Results Conference Call and Live Webcast. I am Alice, the Chorus Call operator.
Temenos AG (TMNSF) Q3 2022 Earnings Call Transcript
Temenos AG (OTCPK:TMNSF) Q3 2022 Earnings Conference Call October 20, 2022 12:30 PM ET Company Participants Max Chuard - Chief Executive Officer Panagiotis Spiliopoulos - Chief Financial Officer Conference Call Participants Charlie Brennan - Jefferies Josh Levin - Autonomous Laurent Daure - Kepler Cheuvreux Justin Forsythe - Credit Suisse Michael Briest - UBS Mohammed Moawalla - Goldman Sachs Michael Foeth - Vontobel Frederic Boulan - Bank of America Operator Ladies and gentlemen, welcome to the Temenos Q3 2022 Results Conference Call and Live Webcast. I'm Maria Reddy, the Chorus Call operator.
TMSNY Financial details
TMSNY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.81 | 12.33 | 13.48 | 13.25 | 13.89 | |
Net income per share | 2.57 | 2.43 | 2.42 | 1.6 | 1.87 | |
Operating cash flow per share | 4.93 | 5.32 | 6.42 | 4.16 | 4.31 | |
Free cash flow per share | 3.81 | 4.12 | 4.99 | 2.69 | 3.08 | |
Cash per share | 2.23 | 1.82 | 2.04 | 1.74 | 1.48 | |
Book value per share | 6.32 | 7.27 | 6.62 | 7.72 | 9.47 | |
Tangible book value per share | -17.26 | -15.9 | -15.65 | -13.75 | 9.47 | |
Share holders equity per share | 6.32 | 7.27 | 6.62 | 7.72 | 9.47 | |
Interest debt per share | 17 | 13.95 | 13.68 | 12.04 | 10.93 | |
Market cap | 11.07B | 10.19B | 9.85B | 3.93B | 6.74B | |
Enterprise value | 12.1B | 11.06B | 10.67B | 4.68B | 7.39B | |
P/E ratio | 61.15 | 58.25 | 56.83 | 34.36 | 50.02 | |
Price to sales ratio | 11.39 | 11.49 | 10.19 | 4.14 | 6.74 | |
POCF ratio | 31.91 | 26.62 | 21.41 | 13.2 | 21.71 | |
PFCF ratio | 41.26 | 34.34 | 27.52 | 20.39 | 30.38 | |
P/B Ratio | 24.88 | 19.48 | 20.75 | 7.11 | 9.88 | |
PTB ratio | 24.88 | 19.48 | 20.75 | 7.11 | 9.88 | |
EV to sales | 12.45 | 12.47 | 11.04 | 4.93 | 7.39 | |
Enterprise value over EBITDA | 32.38 | 28.25 | 28 | 14.8 | 22.37 | |
EV to operating cash flow | 34.85 | 28.89 | 23.2 | 15.72 | 23.83 | |
EV to free cash flow | 45.07 | 37.26 | 29.81 | 24.28 | 33.35 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0.04 | 0.05 | 0.03 | |
Debt to equity | 2.64 | 1.87 | 2.02 | 1.52 | 1.12 | |
Debt to assets | 0.51 | 0.44 | 0.43 | 0.38 | 0.33 | |
Net debt to EBITDA | 2.74 | 2.22 | 2.15 | 2.37 | 1.99 | |
Current ratio | 0.8 | 0.74 | 0.55 | 0.48 | 0.49 | |
Interest coverage | 10.49 | 8.82 | 11.07 | 7.5 | 8.91 | |
Income quality | 1.63 | 1.88 | 2.18 | 2.04 | 2.3 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0.29 | 0.36 | 0.41 | 0.65 | 0.66 | |
Sales general and administrative to revenue | 0.1 | 0.08 | 0.09 | 0.09 | 0 | |
Research and developement to revenue | 0.33 | 0.37 | 0.35 | 0.36 | 0 | |
Intangibles to total assets | 0.71 | 0.75 | 0.71 | 0.69 | 0.65 | |
Capex to operating cash flow | -0.23 | -0.22 | -0.22 | -0.35 | -0.29 | |
Capex to revenue | -0.08 | -0.1 | -0.11 | -0.11 | -0.09 | |
Capex to depreciation | -0.6 | -0.57 | -0.67 | -0.74 | -0.68 | |
Stock based compensation to revenue | 0.04 | 0.01 | 0.05 | 0.06 | 0 | |
Graham number | 19.13 | 19.94 | 18.97 | 16.65 | 19.96 | |
ROIC | 0.12 | 0.13 | 0.13 | 0.09 | 0.11 | |
Return on tangible assets | 0.27 | 0.32 | 0.27 | 0.17 | 0.17 | |
Graham Net | -20.72 | -18.65 | -19.51 | -19 | -17.65 | |
Working capital | -132.76M | -157.71M | -394.27M | -480.98M | -480.46M | |
Tangible asset value | -1.21B | -1.14B | -1.12B | -985.71M | -841.62M | |
Net current asset value | -1.34B | -1.25B | -1.28B | -1.24B | -1.18B | |
Invested capital | 2.64 | 1.87 | 2.02 | 1.52 | 1.12 | |
Average receivables | 181.06M | 327.99M | 289.72M | 270.75M | 305.98M | |
Average payables | 125.42M | 119.16M | 29.33M | 41.25M | 123.12M | |
Average inventory | -10.05M | -11.79M | -1.74M | 0 | 0 | |
Days sales outstanding | 135.98 | 120.88 | 107.79 | 98.37 | 129.92 | |
Days payables outstanding | 303.54 | 22.41 | 45.18 | 48.39 | 179.63 | |
Days of inventory on hand | -27.73 | -4.25 | 0 | 0 | 0 | |
Receivables turnover | 2.68 | 3.02 | 3.39 | 3.71 | 2.81 | |
Payables turnover | 1.2 | 16.29 | 8.08 | 7.54 | 2.03 | |
Inventory turnover | -13.16 | -85.92 | 5460614.71B | 5342285B | 0 | |
ROE | 0.41 | 0.33 | 0.37 | 0.21 | 0.2 | |
Capex per share | -1.12 | -1.2 | -1.42 | -1.47 | -1.23 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.87 | 3.19 | 3.32 | 3.29 | 4.14 | |
Net income per share | 0.67 | 0.43 | 0.53 | 0.3 | 0.61 | |
Operating cash flow per share | 1.8 | 0.86 | 1.16 | 0.68 | 0.12 | |
Free cash flow per share | 1.48 | 0.54 | 0.87 | 0.38 | 0.11 | |
Cash per share | 1.74 | 1.58 | 2.21 | 1.21 | 1.48 | |
Book value per share | 7.71 | 8.27 | 7.58 | 7.91 | 9.47 | |
Tangible book value per share | -13.73 | -13.35 | -13.7 | -13.01 | 9.47 | |
Share holders equity per share | 7.71 | 8.27 | 7.58 | 7.91 | 9.47 | |
Interest debt per share | 11.8 | 11.91 | 12.22 | 11.55 | 10.7 | |
Market cap | 3.94B | 4.92B | 5.71B | 5.09B | 6.74B | |
Enterprise value | 4.69B | 5.65B | 6.48B | 5.83B | 7.39B | |
P/E ratio | 20.52 | 40.2 | 37.27 | 58.18 | 38.36 | |
Price to sales ratio | 14.16 | 21.71 | 23.9 | 21.52 | 22.61 | |
POCF ratio | 30.53 | 80.49 | 68.24 | 104.09 | 780.17 | |
PFCF ratio | 37.19 | 127.15 | 91.16 | 184.24 | 855.02 | |
P/B Ratio | 7.12 | 8.37 | 10.48 | 8.94 | 9.88 | |
PTB ratio | 7.12 | 8.37 | 10.48 | 8.94 | 9.88 | |
EV to sales | 16.86 | 24.93 | 27.13 | 24.64 | 24.81 | |
Enterprise value over EBITDA | 44.12 | 74.21 | 73.54 | 88.49 | 72.67 | |
EV to operating cash flow | 36.36 | 92.43 | 77.47 | 119.21 | 856.34 | |
EV to free cash flow | 44.28 | 146.01 | 103.48 | 210.99 | 938.51 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0.03 | 0.01 | 0.01 | 0.01 | 0 | |
Debt to equity | 1.52 | 1.43 | 1.6 | 1.45 | 1.12 | |
Debt to assets | 0.38 | 0.37 | 0.39 | 0.38 | 0.33 | |
Net debt to EBITDA | 7.07 | 9.59 | 8.76 | 11.22 | 6.46 | |
Current ratio | 0.48 | 0.49 | 0.42 | 0.41 | 0.49 | |
Interest coverage | 10.29 | 8.1 | 10.27 | 6.74 | 11.76 | |
Income quality | 2.04 | 1.6 | 1.7 | 1.71 | 0.2 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0 | 2.3 | 0.01 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.11 | 0.09 | 0.09 | 0 | |
Research and developement to revenue | 1.23 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.69 | 0.68 | 0.68 | 0.68 | 0.65 | |
Capex to operating cash flow | -0.18 | -0.37 | -0.25 | -0.44 | -0.09 | |
Capex to revenue | -0.08 | -0.1 | -0.09 | -0.09 | 0 | |
Capex to depreciation | -0.63 | -0.69 | -0.63 | -0.66 | -0.02 | |
Stock based compensation to revenue | 0.05 | 0.04 | 0.06 | 0.05 | 0 | |
Graham number | 10.77 | 8.94 | 9.53 | 7.36 | 11.4 | |
ROIC | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | |
Return on tangible assets | 0.07 | 0.04 | 0.05 | 0.03 | 0.05 | |
Graham Net | -18.97 | -18.25 | -18.28 | -19.22 | -17.65 | |
Working capital | -480.98M | -460.26M | -627.12M | -621.33M | -480.46M | |
Tangible asset value | -985.71M | -949.13M | -985.05M | -936.46M | -841.62M | |
Net current asset value | -1.24B | -1.21B | -1.24B | -1.19B | -1.18B | |
Invested capital | 1.52 | 1.43 | 1.6 | 1.45 | 1.12 | |
Average receivables | 294.2M | 296.44M | 314.78M | 254.31M | 286.03M | |
Average payables | 120.6M | 118.65M | 185.49M | 178.95M | 193.02M | |
Average inventory | 0.5 | 0.5 | 1 | -790 | -790.5 | |
Days sales outstanding | 82.85 | 133.87 | 110.19 | 82.14 | 107.53 | |
Days payables outstanding | 80.09 | 178.38 | 365.23 | 151.58 | 164.35 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.09 | 0.67 | 0.82 | 1.1 | 0.84 | |
Payables turnover | 1.12 | 0.5 | 0.25 | 0.59 | 0.55 | |
Inventory turnover | 795877.57B | 98.43M | 43.34M | -68.35K | 0 | |
ROE | 0.09 | 0.05 | 0.07 | 0.04 | 0.06 | |
Capex per share | -0.32 | -0.32 | -0.29 | -0.3 | -0.01 |
TMSNY Frequently Asked Questions
What is Temenos AG stock symbol ?
Temenos AG is a CH stock and trading under the symbol TMSNY
What is Temenos AG stock quote today ?
Temenos AG stock price is $72.41 today.
Is Temenos AG stock public?
Yes, Temenos AG is a publicly traded company.